The countries of the world have long been in a race to identify new technology first and implement it to gain an upper hand among their peers! Ever since the outbreak of the COVID-19 Novel Corona Virus Pandemic, almost all the countries have been trying to find an effective cure or vaccine against this deadly virus! The numbers of infected people have been rising with each passing day and the death toll has also been heavy, due to this virus! Latest reports suggested that atleast 10 different vaccines were in various stages of testing and teams of scientists & researchers have been racing against time to achieve the ultimate COVID vaccine at the earliest! Now, we have some great news coming in from the trans-continental country Russia!

The latest report from Vladim Tarasov, the director of the Institute for Translational Medicine and Biotechnology - Vladimir Tarasov, is that the clinical trials of the world's first COVID-19 vaccine on volunteers at the Sechenov First Moscow State Medical University, has been completed! The first group of volunteers who participated in the human trials of this study, will be discharged on July 15th (Wednesday) and the second batch would be discharged on July 20th (the next Monday)! The Sechenov University was conducting trials for the vaccine developed by Gamalei Institute of Epidemiology and Microbiology, Russia! The trials were begun on June 18th and the success of these trials would mean a lot not just for Russia but the whole world!

Talking about this vaccine and the trials, Tarasov said, "Sechenov University has successfully completed tests on volunteers of the world's first vaccine against the coronavirus!" The main objective of this stage of the trials was to test the vaccine's safety for human health and it seems to have come out successfully! The news agency ANI reports the Director of the Institute of Medical Parasitology, Tropical and Vector-borne Diseases at Sechenov University - Dr. Alexander Lukashev as stating, "The safety of the vaccine is confirmed! It corresponds to the safety of those vaccines that are currently on the market!" Further plans regarding the vaccine development, especially considering the complexity of the epidemiological situation with the virus and plans for scaling up production, are under consideration! Stay tuned for further updates!